Creating New Solutions

THE FLEX VESSEL PREP™ SYSTEM

Creating New Solutions

THE FLEX VESSEL PREP™ SYSTEM

Histology study showing the effect of the FLEX Vessel Prep™ System and the controlled micro-incision

Why FLEX First?

Optimize PAD revascularization of long, complex lesions with micro-incisions:

  • Controlled plaque modification in mixed morphology and asymmetrical lesions

  • Consistent micro-incisions of any length to safely prepare vessels to optimize delivery of the final therapies
  • Create pathways to potentially enhance and facilitate drug access to diseased vessels

Why FLEX First?

Optimize PAD revascularization of long, complex lesions with micro-incisions:

  • Controlled plaque modification in mixed morphology and asymmetrical lesions

  • Consistent micro-incisions of any length to safely prepare vessels to optimize delivery of the final therapies
  • Create pathways to potentially enhance and facilitate drug access to diseased vessels

Histology study showing the effect of the FLEX Vessel Prep™ System and the controlled micro-incision

The FLEX System Difference

Optical Coherence Tomography (OCT) image showing the defined micro-incisions created by the FLEX VP™ System along the plaque wall

The FLEX System Difference

Optical Coherence Tomography (OCT) image showing the defined micro-incisions created by the FLEX VP™ System along the plaque wall

Precise Micro-incisions – Continuous Engagement

Human cadaver studies SEM

Precise Micro-incisions – Continuous Engagement

Human cadaver studies SEM

BENEFITS OF FLEX VESSEL PREP
  • Plaque modification / vessel prep prior to treatment optimizes outcomes
  • Preserve physicians’ choice of therapy
  • Seeking clinically effective, cost-efficient, easy-to-use options
  • Effective plaque modification prior to DCB therapy has potential to improve patient outcomes
BENEFITS OF FLEX VESSEL PREP
  • Plaque modification / vessel prep prior to treatment optimizes outcomes
  • Preserve physicians’ choice of therapy
  • Seeking clinically effective, cost-efficient, easy-to-use options
  • Effective plaque modification prior to DCB therapy has potential to improve patient outcomes

VentureMed Group, Inc. develops and markets innovative endovascular medical devices to solve unmet medical needs in the treatment of PAD and stenoses of AV fistulas and grafts.

VentureMed Group, Inc. develops and markets innovative endovascular medical devices to solve unmet medical needs in the treatment of PAD and stenoses of AV fistulas and grafts.